News
Compugen advances COM701 in ovarian cancer with strong partners, key catalysts ahead, and funding into 2027. Find out why ...
In a candid Reddit post, she voiced out her fears about her father not wanting to draft a will. Notwithstanding his ...
6d
Tech Xplore on MSNAI system discovers visual categories while adapting to new contexts
A new approach called open ad-hoc categorization (OAK) helps AI systems dynamically reinterpret the same image differently ...
Now, as reported by Gallop, recent aggressive efforts by the Department of Homeland Security to poach local law enforcement ...
3don MSN
'Your suffering doesn't matter': Harvard psychologist tackles Jews' 'traumatic invalidation'
After the Hamas-led terror attacks of Oct. 7, 2023, Dr. Miri Bar-Halpern, a psychology instructor at Harvard Medical School, wrote on an Israeli Facebook group offering therapy resources to those ...
There is a common perception that Asian Americans don’t participate in civic life, but a closer read of history illuminates ...
Insights from data and ML algorithms can be invaluable, but be warned — mistakes can be irreversible. These recent high-profile AI blunders illustrate the damage done when things don’t go ...
Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.
A poster was presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL in June titled “Phase 2 trial of Ozuriftamab Vedotin (BA3021), a Conditionally Binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results